
- Volume 0 0
Information Steers Consumers Toward Low-Cost Drugs
CIGNA Pharmacy Management generic-conversions program saved consumers money in 2003. The results showed that consumers will make decisions to save money on medications by using generic prescription drugs when they have access to reliable information regarding their options and cost differences.
CIGNA members using Generics Plus and Generic Solutions programs saved an average of $14 for each 30-day prescription that was converted from a brand name drug to a generic. Self-funded plan sponsors or employers, who pay the balance of the cost of the medications, saved an average of $46 for each monthly medication. CIGNA Pharmacy Management estimates that annual savings in these 2 programs could be in the ballpark of >$12 million.
"Generic medications can be a good choice for many consumers, because they offer therapeutically equivalent benefits at a reduced cost," said Jon Maesner, vice president of policy and strategy for CIGNA Pharmacy Management. "But there are also patients for whom generic medications are not preferable. That's why our voluntary program encourages consumers to discuss their treatment options with their doctors."
Under the Generics Plus and Generic Solutions programs, members who filled a brand name prescription that had a generic equivalent received a letter informing them of their potential savings if they switched to generic alternatives for their prescriptions. Also included with the letter was information from the FDA regarding the safety and effectiveness of generic drugs. Members were urged to discuss with their physician whether a generic alternative would be suitable for them.
Articles in this issue
over 21 years ago
RxPRODUCT NEWS PROFILE: Caduetover 21 years ago
COMPOUNDING HOTLINEover 21 years ago
Case Studiesover 21 years ago
Buddies Are Good for the Heartover 21 years ago
Low-Fat Diet Shows Promise for Prostate Cancerover 21 years ago
Rage Is Connected to Stroke Riskover 21 years ago
InnoLetover 21 years ago
Colace/Peri-Colaceover 21 years ago
TampAlerTover 21 years ago
Low Testosterone Is Linked with Alzheimer's DiseaseNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

















































































































































































































